Cargando…
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
BACKGROUND: The association of pro-inflammatory markers such as interleukin-6 (IL-6) and other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest, however their kinetics, response to current COVID-related treatments, association with disease severity and comparison...
Autores principales: | Copaescu, Ana, James, Fiona, Mouhtouris, Effie, Vogrin, Sara, Smibert, Olivia C., Gordon, Claire L., Drewett, George, Holmes, Natasha E., Trubiano, Jason A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009986/ https://www.ncbi.nlm.nih.gov/pubmed/33815405 http://dx.doi.org/10.3389/fimmu.2021.646095 |
Ejemplares similares
-
Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021) -
The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021) -
Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol
por: Copaescu, Ana-Maria, et al.
Publicado: (2022) -
Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021) -
Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)